Profile
VVOS ABT BSX-PA SYK MDT BSX
Company Name Vivos Therapeutics, Inc. Abbott Laboratories Boston Scientific Corporation Stryker Corporation Medtronic plc Boston Scientific Corporation
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $10.07M $196.11B $175.45B $139.91B $127.61B $110.83B
Employees 0.11K 114.00K 45.00K 53.00K 95.00K 53.00K
CEO R. Kirk Huntsman Robert Ford Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha Michael F. Mahoney
Ratings
VVOS ABT BSX-PA SYK MDT BSX
Quant Rating Score 1 2 3 3 1
Quant Rating Strong Sell Sell Neutral Neutral Strong Sell
Trading
VVOS ABT BSX-PA SYK MDT BSX
Last Close $2.39 $130.03 $122.18 $360.13 $96.28 $101.76
High 52 $6.95 $140.22 $122.18 $403.53 $98.43 $108.14
Low 52 $2.08 $111.1 $122.18 $337.28 $79.61 $88.03
Price vs. 52 Week High -65.61 % -7.27 % 0 % -10.76 % -2.18 % -5.9 %
Price vs. 52 Week Low 14.9 % 17.04 % 0 % 6.77 % 20.94 % 15.6 %
Total Return
VVOS ABT BSX-PA SYK MDT BSX
1 Month Return -17.59 % 1.16 % 0 % -3.82 % 0.52 % 2.54 %
3 Month Return -46.29 % -0.18 % 0 % -5.68 % 3.74 % -1.25 %
6 Month Return -5.91 % -3.54 % 0 % -8.65 % 11.38 % -4.04 %
9 Month Return -32.49 % -0.12 % 0 % -6.61 % 11.86 % -3.41 %
YTD Return -44.29 % 14.96 % 0 % 0.02 % 20.53 % 13.93 %
1 Year Return -15.55 % 11.01 % 0 % -7.35 % 13.27 % 12.65 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
VVOS ABT BSX-PA SYK MDT BSX
Dividend Yield Percentage (TTM) - 2.13 % - 0.93 % 2.84 % -
Dividend Paid and Capex Coverage Ration (TTM) -87.22 % 1.46 % 5.44 % 2.47 % 1.29 % 5.44 %
Dividend Per Share (TTM) - 2.4 % - 3.4 % 2.83 % -
Payout Ratio (TTM) - 61.99 % - 39.56 % 75.84 % -
Growth
VVOS ABT BSX-PA SYK MDT BSX
Asset Growth 42.44 % - 11.34 % 1.89 % 12.12 %
Gross Profit Growth 9.04 % 15.39 % 10.39 % 3.58 % 16.26 %
Revenue Growth 8.91 % 5.67 % 11.16 % 3.62 % 17.61 %
Revenue 3 Year -84.94 % 1.9 % 34.71 % 10.52 % 36.16 %
Revenue 5 Year -86.95 % 29.99 % 71.94 % 20.96 % 47.52 %
Revenue 10 Year -63.53 % 83.13 % 148.82 % 41.05 % 104.22 %
EBIT Growth 35.41 % 12.74 % 15.72 % 14.42 % 18.25 %
Net Income Growth 18.02 % -51.32 % 8.45 % 26.82 % 16.38 %
Net Income 3 Yeari Growth Per Share 90.72 % -5.58 % 36.22 % -3.39 % 72.31 %
Net Income 5 Yeari Growth Per Share 89.76 % 47.3 % 99.44 % 1.52 % -62.7 %
Net Income 10 Yeari Growth Per Share 88 % 24.34 % 122.27 % 48.51 % 1502.13 %
Operating Income Growth 35.41 % 17.92 % 11.14 % 15.77 % 20.82 %
Operating Cash Flow Growth (CFG) -6.24 % - 18.91 % 3.79 % 37.24 %
Operating 3 Year CFG 86.35 % -100 % 90.21 % 0.13 % 77.55 %
Operating 5 Year CFG 76.5 % -100 % 51.22 % 1.55 % 76.92 %
Operating 10 Year CFG 78.02 % -100 % 452.85 % 22.45 % 143.61 %
EPS Growth 80.07 % -51.24 % 8.02 % 31.05 % 16.61 %
EPS Diluted Growth 80.07 % -51.31 % 8.25 % 30.8 % 16.52 %
Book Value Per Share 370.1 % -100 % 8.31 % -1.16 % 11.25 %
Share Holder 3 Year Equity Growth Per Share -94.73 % -100 % 33.52 % -4.58 % 26.58 %
Share Holder 5 Year Equity Growth Per Share 126.73 % -100 % 68.35 % -1.29 % 48.35 %
Share Holder 10 Year Equity Growth Per Share -84.84 % -100 % 159.56 % -23.12 % 186.31 %
Dividend Per Share Growth - 6.54 % 5 % 1.11 % -100 %
Dividend 3 Year Growth Per Share - 25.03 % 20.89 % 10.78 % -100 %
Dividend 5 Year Growth Per Share - 63.45 % 46.18 % 29.33 % -
Dividend 10 Year Growth Per Share - 140.85 % 142.84 % 128.74 % -
Debt Growth -24.21 % - 5.23 % 13.95 % 17.44 %
Free Cash Flow Growth -4 % - 22.83 % -0.29 % 55.31 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2025 30 Apr 2025 31 Dec 2024
Profitability
VVOS ABT BSX-PA SYK MDT BSX
Gross Profit Margin TTM 55.74 % 55.51 % 69.01 % 63.54 % 62.27 % 69.01 %
Return on Assets TTM -66.7 % 7.75 % 6.77 % 6.78 % 5.22 % 6.77 %
Return on Equity TTM -351.28 % 13.18 % 12.87 % 15.04 % 9.83 % 12.87 %
Return on Capital Employed TTM -86.57 % 11.56 % 10.62 % 14.07 % 7.63 % 10.62 %
Net Income Per EBT TTM 100 % 77.06 % 85.38 % 71.91 % 83.61 % 85.38 %
EBT Per Ebit TTM 108.51 % 105.19 % 85.24 % 80.09 % 91.74 % 85.24 %
EBIT Per Revenue TTM -91.02 % 18.16 % 19.78 % 22.44 % 17.87 % 19.78 %
Cash Flow To Debt Ratio TTM -349.38 % 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Receivables Turnover TTM 8.11 4.26 7.1 6.22 5.44 7.1
Payables Turnover TTM 3.64 4.78 6.21 - 5.08 6.21
Inventory Turnover TTM - 2.94 2.13 1.72 2.13 2.13
Fixed Asset Turnover TTM 191.88 % 385.33 % 468.06 % 647.99 % 485.18 % 468.06 %
Asset Turnover TTM 67.53 % 52.66 % 47.01 % 52.5 % 38.05 % 47.01 %
Operating Cash Flow Per Share TTM -1.31 5.22 3.12 13.19 5.55 3.12
Free Cash Flow Per Share TTM -1.32 3.96 2.55 11.2 4.06 2.55
Cash Per Share TTM 28.16 % 442.64 % 85.99 % 1071.9 % 649.63 % 85.99 %
Operating Cash Flow Sales Ratio TTM -83.1 % 20.57 % 23.04 % 20.08 % 20.46 % 23.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.3 % 75.85 % 81.6 % 84.91 % 73.19 % 81.6 %
Cash Flow Coverage Ratios TTM -349.38 % 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Price To Free Cash Flows Ratio TTM -0.7 28.35 29.36 32.67 24.51 29.36
Price To Operating Cash Flows Ratio TTM -1.3 21.59 23.95 27.74 17.93 23.95
Price Cash Flow Ratio TTM -1.3 21.59 23.95 27.74 17.93 23.95
Income Statement (TTM)
VVOS ABT BSX-PA SYK MDT BSX
Revenue $0.02B $44.33B $20.07B $25.12B $33.54B $20.07B
Gross Profit $0.01B $24.61B $13.85B $15.43B $21.91B $13.85B
Gross Profit Ratio 60% 55.51% 69.01% 61.44% 65.32% 69.01%
EBITDA $-0.01B $11.33B $3.73B $5.69B $9.22B $3.73B
Net Income $-0.01B $6.52B $2.89B $3.25B $4.66B $2.89B
EPS Diluted -2.22 3.72 1.94 8.4 3.61 1.94
Balance Sheet (MRQ)
VVOS ABT BSX-PA SYK MDT BSX
Long Term Debt $0B $13.52B $9.37B $14.86B $25.64B $9.37B
Total Liabilities $0.01B $33.51B $17.39B $25.42B $43.42B $17.39B
Total Equity $0.01B $47.9B $22B $22.42B $48.26B $22B
Total Investments $0B $1.24B $0.56B $0.09B $6.75B $0.56B
Total Debt $0B $15.28B $11.15B $14.86B $28.52B $11.15B
Total Assets $0.02B $81.41B $39.4B $47.84B $91.68B $39.4B
Cash Flow Statement (TTM)
VVOS ABT BSX-PA SYK MDT BSX
Net Income $-0.01B $13.4B $1.85B $3.25B $4.69B $1.85B
Inventory $0B $-0.06B $-0.23B $0B $-0.29B $-0.23B
Dividends Paid $0B $-3.84B $0B $-1.28B $-3.59B $0B
Operating Cash Flow $-0.01B $8.56B $3.44B $5.04B $7.04B $3.44B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.76B $-1.86B $-0.79B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 112.68
ADGM Adagio Medical Holdings, Inc. 0.985
AEMD Aethlon Medical, Inc. 1.96
AFIB Acutus Medical, Inc. 0.0002
AHCO AdaptHealth Corp. 10.2
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 186.77
ALUR Allurion Technologies Inc. 1.12
AMIX Autonomix Medical, Inc. Common Stock 0.3833
ANIK Anika Therapeutics, Inc. 10.21
AORT Artivion, Inc. 36.6
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 3.72
ARAY Accuray Incorporated 0.5476
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 13.36
AVNS Avanos Medical, Inc. 14.9
AVR Anteris Technologies Global Corp. Common Stock 5.71
AXDX Accelerate Diagnostics, Inc. 0.034
ETFs With Exposure to VVOS
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00002 336.65
VXF Vanguard Extended Market Index Fund 0.00011 216.28
IWC iShares Micro-Cap ETF 0.00221 166.03
VUN.TO Vanguard U.S. Total Market Index ETF 0.00002 124.53
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00002 116.8
VGRO.TO Vanguard Growth ETF Portfolio 0.00001 44.16
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00001 55.46
VBAL.TO Vanguard Balanced ETF Portfolio 0.00001 37.77
VCNS.TO Vanguard Conservative ETF Portfolio 0 32.11
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.4
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 27.01
DFAC Dimensional U.S. Core Equity 2 ETF 0.00002435 40.79
VTSAX Vanguard Total Stock Market Index Fund 0.00002 163.89
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00011 164.01
VITSX Vanguard Total Stock Market Index Fund 0.00002 163.92
DFSU Dimensional US Sustainability Core 1 ETF 0.00010024 43.45
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00015 164.02
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
VTS.AX Vanguard US Total Market Shares Index ETF 0.00002 475.91
VEMPX Vanguard Extended Market Index InstlPlus 0.00011 404.75
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00002 307.49
Unlock